Wednesday, February 17, 2010

Clemons Memorial Lecture

"Varicella-Zoster Infections: The New Frontier"
Anne Gershon, MD
Professor of  Pediatrics,
Columbia University Medical Center New York, New York

Surrogate Endpoints and Clinical Trials
 

"Principles of Surrogate Endpoints in Clinical Studies"  
Speaker:  Paul Griffiths, MD

"Viral Loads in Phase I, II and III Trials of New Antiviral Drugs" 
Speaker:  Barbara Styrt, MD, MPH

"Phase 2 and 3 Trials of Maribavir"
Speaker:  Michael Boeckh, MD
Not available

"Detection of CMV in Multiple Blood Compartments"
Speaker:  Raymond Razonable, MD
Not available

"Preemptive Therapy Based on Real Time Measurement of CMV Viral Load in Solid Organ Transplant Recipients"
Speaker: Nina Singh, MD

"Congenital CMV Viral Load and Other Biomarkers: Challenges and Potential Possibilities"
Speaker:  Suresh Boppana, MD

"Congenital CMV Viral Load - CASG Trials"
Speakers:  David Kimberlin, MD & Scott James, MD


Thursday, February 18, 2010 

"Welcome"
Speaker: Richard Whitley, MD
Not available

"Year in Review"
Speaker:  Walla Dempsey, PhD
Not available 

"Adenovirus Infections in Transplant Recipients"
Speaker:  Lesia Dropulic, MD
Not available  

"BK Virus CASG 209 Update"
Speaker:  Ajit Limaye, MD

"CASG 103-104 Update"
Speaker: David Kimberlin, MD

"Global Perspectives for H1N1"
Speaker: Fred Hayden, MD

"Resistance Monitoring for Influenza in the US and the World"
Speaker:  Lisa Gubareva, MD, PhD  

"Surrogate Endpoints for Influenza"
Speaker: Michael Ison, MD

"CASG 114 Influenza Update"
Speaker: David Kimberlin, MD

"Status of CMX001"
Speaker:  Wendy Painter, MD  

"CASG 214 - CMX001"
Speaker: John Gnann, Jr., MD
 
"ACV plus CMX001 Therapy of Encephalitis" 
Speaker:  Earl Kern, PhD

"CASG 112 CMV Update"
Speaker:  David Kimberlin, MD  

"Resistance in CMV"
Speaker:  Mark Prichard, PhD
  

"Peramivir Studies CASG 117 and 118"
Speaker:  David Kimberlin, MD

"Status of Permaivir - Globally"
Speaker:  Phil Collis, PhD
     

 Breakout Sessions 

"Pediatrics - CMV "
Speakers:  David Kimberlin, MD and Paul Griffiths, MD   

"Adult - Immunocompromised Host: BK virus/Adenovirus/EBV (CASG 209 and 214)"
Speaker:  John Gnann, MD


Friday, February 19, 2010

"Report from Surrogate Endpoint Workshop"
Speaker: Paul Griffiths, MD 
Not available 

"HSE CASG 204 Update"
Speaker: John Gnann, MD,        

"CASG 106 Update"
Speaker:  David Kimberlin, MD

Breakout Sessions 

 "Pediatrics:  Influenza / Adenovirus"
  Speaker:  David Kimberlin, MD      
 "Adults:  Influenza and Respiratory Viruses:  New Directions?"
  Speaker:  John Gnann, MD

 

 

 

Committed to advancing clinical care, research, education and advocacy to improve the health of the children of Alabama, the region and the world

The UAB Department of Pediatrics is dedicated to improving the health of children; discovering and applying important new knowledge to improve the outcomes for pediatric disorders; educating patients, families, and health care providers and training the next generation of pediatric providers and leaders in medicine.

Research

We invest in people and programs to fuel new discoveries; we support the careers of pediatric investigators who will discover new knowledge and help us change the outcome for the children of Alabama.

Education

UAB Pediatrics provides comprehensive training programs for all levels of learners. Our clerkship, residency, and subspecialty fellowship programs are among the best in the nation.

Patient Care

For more than 50 years, the partnership between UAB and Children’s of Alabama has provided outstanding care to the youngest, most vulnerable patients and established Birmingham as a nationally renowned center for pediatric medicine.

Upcoming Events